Gene · 4882
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction. | Front Cardiovasc Med | 2022 | 35783848 | PubTator, text mining | PubMed |
| Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics. | Dis Markers | 2022 | 35774848 | PubTator, text mining | PubMed |
| Development of allergen-specific IgE in a food-allergy model requires precisely timed B cell stimulation and is inhibited by Fgl2. | Cell Rep | 2022 | 35767958 | PubTator, text mining | PubMed |
| IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma. | Cell Death Dis | 2022 | 35760783 | PubTator, text mining | PubMed |
| Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature. | Front Endocrinol (Lausanne) | 2022 | 35757432 | PubTator, text mining | PubMed |
| Editorial: Novel Insights Into the Genetics of Growth Disorders. | Front Genet | 2022 | 35754806 | PubTator, text mining | PubMed |
| Pathway importance by graph convolutional network and Shapley additive explanations in gene expression phenotype of diffuse large B-cell lymphoma. | PLoS One | 2022 | 35749395 | PubTator, text mining | PubMed |
| Biallelic KIF24 Variants Are Responsible for a Spectrum of Skeletal Disorders Ranging From Lethal Skeletal Ciliopathy to Severe Acromesomelic Dysplasia. | J Bone Miner Res | 2022 | 35748595 | PubTator, text mining | PubMed |
| Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method. | Int J Mol Sci | 2022 | 35743172 | PubTator, text mining | PubMed |
| Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization. | Int J Mol Sci | 2022 | 35742995 | PubTator, text mining | PubMed |
| Heterozygous NPR2 Variants in Idiopathic Short Stature. | Genes (Basel) | 2022 | 35741827 | PubTator, text mining | PubMed |
| Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart. | Biology (Basel) | 2022 | 35741432 | PubTator, text mining | PubMed |
| Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States. | Biology (Basel) | 2022 | 35741380 | PubTator, text mining | PubMed |
| NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis. | Diagnostics (Basel) | 2022 | 35741227 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure. | Front Cardiovasc Med | 2022 | 35722101 | PubTator, text mining | PubMed |
Bovine In Vitro Oocyte Maturation and Embryo Production Used as a Model for Testing Endocrine Disrupting Chemicals Eliciting Female Reproductive Toxicity With Diethylstilbestrol as a Showcase Compound. | Front Toxicol | 2022 | 35686045 | PubTator, text mining | PubMed |
| Distinct Gene Expression Patterns of Calcium Channels and Related Signaling Pathways Discovered in Lymphomas. | Front Pharmacol | 2022 | 35685639 | PubTator, text mining | PubMed |
| Long noncoding RNAs (lncRNAs) in human lymphomas. | Genes Dis | 2022 | 35685474 | PubTator, text mining | PubMed |
| Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide. | Int J Mol Sci | 2022 | 35682595 | PubTator, text mining | PubMed |
| [Distribution and prognostic value of LymphGen genotyping in patients with diffuse large B-cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35680629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4882/papers?page=18